For 50 years, SCHILLER has been committed to the fight against sudden cardiac death. The success story began with the launch of a handy emergency electrocardioscope. In one stroke, the company not only made a name for itself, but also set new standards.
SCHILLER was founded in 1974 by Alfred E. Schiller. Starting in a four-room flat as a one-man business, the company has become a successful group with about 1400 employees, 31 subsidiaries and a global sales network. Today, SCHILLER is a world-leading manufacturer and supplier of devices for cardiopulmonary diagnostics, rescue and patient monitoring as well as software solutions for the medical industry.
For 50 years, SCHILLER has been committed to the fight against sudden cardiac death. The success story began with the launch of a handy emergency electrocardioscope. In one stroke, the company not only made a name for itself, but also set new standards. Thanks to suitable therapies and rehabilitation measures, physicians can thus protect people of all age groups from sudden cardiac death.
As success grew, so did the product portfolio: devices such as blood pressure monitors and spirometers enhanced the range, and complete diagnostic stations and monitoring devices started being produced for clinics and medical practices. Similarly, the production sites and competence centres also expanded. In addition to the headquarters in Baar (Switzerland), a competence centre was established in Wissembourg (France), specialising in the fields of defibrillation and monitoring.
Another competence centre opened in Graz (Austria): The company medilog became part of the SCHILLER Group. This new alliance allowed SCHILLER to acquire additional know-how in the field of high-end long-term ECG. The next major step was achieved through the alliance with GANSHORN, a company specialising in the field of pulmonary function diagnostics, which is now also a part of the SCHILLER Group.
From a one-man business in a four-room apartment in 1974, SCHILLER has grown into a successful group with around 1,400 employees, 30 subsidiaries and a global sales network. It all started with the small and portable emergency ECG device MINISCOPE MS-1. Shortly after, SCHILLER became the first ECG manufacturer to integrate an interpretation program directly into an ECG device. SCHILLER built on this extraordinary achievement and developed into a globally renowned brand and reference in the ECG sector at an early stage of the company’s history.
Despite the company’s continuous growth, size is not as important to SCHILLER as strength. SCHILLER relies on a motivated team, creativity, openness to new ideas and pioneering courage. “The Art of Diagnostics” inspires us to constantly look ahead and further develop our portfolio.
Today, in 2024, SCHILLER is a leading global manufacturer and supplier of devices for cardiopulmonary diagnostics, defibrillation, and patient monitoring as well as software solutions for the medical sector.
And within the record time of only five seconds. During this time there were mainframe computers which needed three minutes for the same result. The CARDIOVIT CS-6 device was such a revolution that SCHILLER AG could hardly keep up with production.
This is another pioneering achievement by the innovative Swiss medical technology company. It develops and markets the new spirometry sensor SPIROVIT SP-100.
He was one of the four founders in 1989 and Christian Ecker is still CEO of SCHILLER Austria today. At that time, he had already been working for the Tatschl company, which sold SCHILLER devices in Austria, for several years. He therefore already knew the market. In the spring of 1989, things really got going with the founding of SCHILLER Austria and an inauguration party.
“Our bestsellers back then were the AT-6, as ECG device with spirometry and the AT-3 with its diagnostic software,” recalls Christian Ecker. “Some of these devices are still on the market with enthusiasts who use the latest SCHILLER products in their practices and clinics, but who simply value these long-lasting initial products too much to put them aside,” says Christian Ecker. Through digitalization, thermal printers and LCD displays, SCHILLER has turned the Austrian market upside down. The market share in the ECG sector in Austria is consistently around 60%. Today, the CARDIOVIT FT-1, AT-102 G2 and CS-104 are at the top of the popularity rankings.
SCHILLER developed the Eastern European market from Austria. In the early 1990s, subsidiaries were established in Hungary, Poland, Croatia, Slovenia, Serbia, the Czech Republic, Slovakia and in the Ukraine, as well as in various Balkan states. “We established branches, sales offices or subsidiaries depending on the legal possibilities,” Christian Ecker recounts of the expansion.
Monitoring of patients in the MRI environment is not often an easy task, particularly for those under anaesthesia such as children or neonates. Patient monitoring in the MRI room allows physicians to remain informed of changes to the patient’s vitals that may otherwise go undetected.
The MAGLIFE RT-1 has been engineered to meet the needs of today’s complex MRI environment and is compatible with MRI systems from any manufacturer that have a field strength between 0.2 and 3 tesla. Use of the MAGLIFE RT-1 is versatile, designed for everyday use, from monitoring under anaesthesia to cardiac imaging.
FRED easy G2, the latest defibrillator in SCHILLER’s product portfolio, is suitable for life-saving and advanced immediate measures. Compact, lightweight, smart and ready for action, the device perfectly complements every emergency kit, offering mobility and flexibility in a time-critical situation.
The CARDIOVIT FT-2 is the first mobile ECG device from SCHILLER with an optional thermal printer. Developed specifically for the requirements of a hospital the CARDIOVIT FT-2 impresses with its innovative concept: 15″ multi-touch display, the latest cyber security as well as extensive connectivity options.
The medilogFD is the newest SCHILLER 12-lead Holter ECG for a spatial heart health analysis. The 12-lead Holter allows assessing the full spectrum of cardiac ECG conditions. It instantly detects atrial fibrillation/atrial flutter based on true P-wave analysis. The optional SpO2 sensor provides additional respiratory information.
However, resting on its laurels is not an option for SCHILLER because innovation is a priority for this Swiss company. More innovations are close to the testing phase.
© Schiller Americas 2025 Developed by Schiller Americas
Share your information with us to receive advice from a product specialist. By submitting the form, you will be able to download our Product Catalog to learn about all the solutions we offer.
